Entera Bio Ltd. Discloses Warrant Agreement and Equity Sales
Ticker: ENTX · Form: 8-K · Filed: Mar 17, 2025 · CIK: 1638097
| Field | Detail |
|---|---|
| Company | Entera Bio LTD. (ENTX) |
| Form Type | 8-K |
| Filed Date | Mar 17, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: warrants, equity-securities, definitive-agreement
Related Tickers: ENTX
TL;DR
Entera Bio Ltd. filed an 8-K detailing a warrant agreement with an exercise price of $5.85, potentially impacting share count.
AI Summary
Entera Bio Ltd. announced on March 16, 2025, the entry into a material definitive agreement related to warrants. These warrants are exercisable for half of an Ordinary Share at an exercise price of $5.85 per share. The company also disclosed unregistered sales of equity securities and provided financial statements and exhibits.
Why It Matters
This filing indicates potential future dilution for existing shareholders if warrants are exercised, and signals activity in the company's equity structure.
Risk Assessment
Risk Level: medium — The filing involves unregistered sales of equity securities and warrants, which can lead to dilution and increased share count.
Key Numbers
- $5.85 — Warrant Exercise Price (Price at which warrants can be exercised for Ordinary Shares)
Key Players & Entities
- Entera Bio Ltd. (company) — Registrant
- $5.85 (dollar_amount) — Exercise price per Ordinary Share for warrants
- March 16, 2025 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement entered into by Entera Bio Ltd.?
The filing indicates a material definitive agreement related to warrants, which are exercisable for half of an Ordinary Share at an exercise price of $5.85 per share.
When was the earliest event reported in this 8-K filing?
The earliest event reported is dated March 16, 2025.
What is the exercise price for the warrants mentioned in the filing?
The exercise price for the warrants is $5.85 per Ordinary Share.
What other types of disclosures are included in this 8-K filing besides the material agreement?
The filing also includes disclosures on unregistered sales of equity securities and financial statements and exhibits.
What is the SIC code for Entera Bio Ltd.?
The Standard Industrial Classification (SIC) code for Entera Bio Ltd. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 17, 2025 regarding Entera Bio Ltd. (ENTX).